benzimidazole has been researched along with Helicobacter Infections in 2 studies
1H-benzimidazole : The 1H-tautomer of benzimidazole.
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CS | 1 |
Liu, JF | 1 |
Lin, HJ | 1 |
Lin, CD | 1 |
Tang, CH | 1 |
Lu, DY | 1 |
Sing, YT | 1 |
Chen, LY | 1 |
Kao, MC | 1 |
Kuo, SC | 1 |
Lai, CH | 1 |
Iwao, E | 1 |
Yamamoto, K | 1 |
Yokoyama, Y | 1 |
Hirayama, F | 1 |
Haga, K | 1 |
2 other studies available for benzimidazole and Helicobacter Infections
Article | Year |
---|---|
Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Cell Adhesion; Cell | 2012 |
Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori.
Topics: Animals; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Gerbilli | 2004 |